Sesen Bio: Better watch than trade

Sesen Bio loses in market comparison

Compared to the average annual performance of stocks in the same sector (“healthcare”), Sesen Bio is down more than 82 percent with a return of -55.72 percent. The “biotechnology” sector has a median return over the past 12 months of 26.18 percent. Again, Sesen Bio is well below that at 81.9 percent. This performance of the stock over the past year leads to a “Sell” rating in this category.

An overview of sentiment

In addition to analyses from banking institutions, the yardstick for sentiment around stocks is the long-term sentiment among investors and users on the Internet. The number of posts over a longer period of time as well as the change in sentiment provide a good long-term picture of the sentiment situation. We analyzed Sesen Bio’s stock for these two factors. The post count or discussion intensity showed medium activity, from which we believe a “hold” rating can be generated. The rate of change in sentiment for Sesen Bio shows a change to positive. This corresponds to a “buy” rating. In this respect, we give Sesen Bio’s stock a “Buy” rating with respect to the long-term sentiment picture.

Investors are positive

Social media sentiment has been neutral in recent days. On five days, the sentiment barometer pointed to green, negative discussions could not be recorded. For the most part, investors were neutral on a total of eight days. In the past one or two days, on the other hand, investors talked more about positive topics related to the company Sesen Bio. As a result, the editorial team rates the share with a “buy”. In summary, this results in a “Buy” rating for investor sentiment.

Sesen Bio: The RSI with new signals

To assess whether a security is currently “overbought” or “oversold” the upward and downward movements over time can be put into relation. This provides the so-called Relative Strength Index (RSI), an indicator from technical analysis which is often used in the financial market. We now evaluate Sesen Bio using the shorter-term RSI of the last 7 days as well as the slightly longer-term RSI on a 25-day basis. First, the 7-day RSIthis is currently at 57.14 points, which means that Sesen Bio stock is neither overbought nor oversold. Accordingly, it gets a “hold” rating. Now to the RSI25Also here, Sesen Bio is neither overbought nor -sold (value39), thus the stock receives a “Hold” rating for the RSI25 as well. Thus, Sesen Bio receives a “Hold” rating for this point of our analysis.